Lycopene-enhanced pink cavendish bananas for heart health
Introducing lycopene-rich Cavendish bananas, developed through gene editing, to offer a heart-healthier alternative in the banana market. These visually appealing pink bananas aim to reduce inflammation and risk of heart disease, currently undergoing TRL4 validation.
Overview
Our innovative approach aims to revolutionize the banana market by introducing the lycopene-enhanced pink Cavendish banana. This unique fruit not only captures attention with its distinctive color but also offers significant health benefits, such as reducing inflammation and lowering the risk of heart disease and certain cancers. This is achieved by increasing lycopene content, a powerful antioxidant, through a specialized gene editing platform.
Technical specifications
Our technology employs gene editing to modify the lycopene beta-cyclase and lycopene epsilon-cyclase enzymes, which are crucial in the carotenoid biosynthesis pathway. By performing total or partial knockouts of these genes, we effectively accumulate lycopene in the bananas, achieving a pink hue. Our method ensures the bananas are free of foreign DNA and are considered non-genetically modified in most jurisdictions. The current focus is on testing 23 edited lines, with six promising lines undergoing glasshouse trials for further phenotyping and carotenoid analysis.
Technology readiness level
The development of lycopene-enhanced Cavendish bananas is currently at Technology Readiness Level 4, with glasshouse trials in progress. Previous field trials of our gene editing platform have reached TRL6, indicating a proven capability in a similar application. Future plans include scaling up to field trials in Australia to validate the best performing lines and confirm their non-GM status through further genetic analysis.
About Queensland University of Technology
Queensland University of Technology (QUT) is a major Australian public research university in Brisbane with two inner-city campuses and a practical, industry-focused culture. Industry partners tap shared core laboratories and technical staff through the Central Analytical Research Facility, and collaborate with QUT groups at the Translational Research Institute alongside hospital partners. A dedicated Office of Industry Engagement brokers collaborative and contract research, while entrepreneurship programs and commercialization pathways help convert university IP into ventures and licenses. Research is sustained by competitive national funding, including the Australian Research Council and National Health and Medical Research Council, with added support from programs such as the Medical Research Future Fund.
Inquire about this partnering listing
Industry applications
delivered to your inbox.